Form 4: Replimune Group Officer Acquires Shares and Stock Options

Andrew Schwendenman, Chief Accounting Officer of Replimune Group, reports acquisition of shares and stock options.

Summary

• Andrew Schwendenman, Chief Accounting Officer of Replimune Group, filed a Form 4.
• The form reports changes in beneficial ownership of Replimune Group's securities.
• On April 1, 2025, Schwendenman acquired 33,333 shares of common stock through restricted stock units (RSUs).
• Schwendenman also acquired options to purchase 50,000 shares of common stock at an exercise price of $8.40.
• Following these transactions, Schwendenman beneficially owns 71,571 shares of common stock directly and options for 50,000 shares.
• The RSUs vest over time, with 25% vesting on May 15, 2026, and the remainder in three equal annual installments until May 15, 2029.
• The stock options vest with 25% on April 1, 2026, and the remainder in 36 approximately equal monthly installments thereafter.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of shares and options by an officer could be interpreted slightly positively, but it's not a strong indicator.

Positives

• The acquisition of shares and options by a company officer can be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the trading activities of company insiders.

Key Dates

Keywords

Replimune Group, Schwendenman, Form 4, Beneficial Ownership, Stock Options, RSUs, Securities, Officer